Rigel Pharmaceuticals (RIGL) Retained Earnings (2010 - 2026)
Rigel Pharmaceuticals (RIGL) posted quarterly Retained Earnings of -$128000.0 for Q1 2026, down 6300.0% year-over-year from $2064.5 in Q1 2025, and up 99.99% quarter-over-quarter from -$1.0 billion in Q4 2025.
Powered by 
Analysis
Rigel Pharmaceuticals (RIGL) Retained Earnings (2010 - 2026) Analysis & Trends
Rigel Pharmaceuticals' Retained Earnings history runs 17 years deep, the most recent figure standing at -$128000.0 for Q1 2026.
- In Q1 2026, Retained Earnings fell 6300.0% year-over-year to -$128000.0; the TTM figure through Mar 2026 stood at -$128000.0 (down 6300.0% YoY), while the FY2025 annual figure was -$1.0 billion, down 10230510.0% from the prior year.
- Retained Earnings for Q1 2026 stood at -$128000.0, up from -$1.0 billion in the prior quarter.
- The five-year high for Retained Earnings was $10000.0 in Q4 2024, with the low at -$1.4 billion in Q2 2024.
- The 5-year median for Retained Earnings is -$1.0 billion (2025), against an average of -$709.0 million.
- The sharpest annual moves came in 2022 and 2023: Retained Earnings slumped 17298350.0% in 2022, then soared 105.23% in 2023.
- Rigel Pharmaceuticals' Retained Earnings stood at -$153000.0 in 2022, then surged by 105.23% to $8000.0 in 2023, then climbed by 25.0% to $10000.0 in 2024, then slumped by 10230510.0% to -$1.0 billion in 2025, then surged by 99.99% to -$128000.0 in 2026.
- Business Quant data shows RIGL's Retained Earnings at -$128000.0 in Q1 2026, -$1.0 billion in Q4 2025, and -$1.3 billion in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.27 Bn | 131.42 Bn | 2.84 Bn | 15.69 Bn |
| 2 | Regeneron Pharmaceuticals | 85.55 Bn | 77.56 Bn | 3.93 Bn | 37.62 Bn |
| 3 | Argenx Se | 63.45 Bn | 58.27 Bn | 1.37 Bn | 558.00 Mn |
| 4 | Moderna | 57.73 Bn | 52.59 Bn | 52.00 Mn | 5.10 Bn |
| 5 | Revolution Medicines | 44.08 Bn | 44.08 Bn | - | -4.00 Bn |
| 6 | BeOne Medicines | 39.95 Bn | 34.85 Bn | 1.53 Bn | 13.05 Bn |
| 7 | Alnylam Pharmaceuticals | 35.14 Bn | 31.84 Bn | 992.69 Mn | -6.33 Bn |
| 8 | Royalty Pharma | 28.44 Bn | 27.60 Bn | - | 4.38 Bn |
| 9 | Insmed | 27.32 Bn | 26.16 Bn | 358.27 Mn | 6.57 Bn |
| 10 | Rigel Pharmaceuticals | 902.02 Mn | 806.69 Mn | 70.18 Mn | -997.10 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -997.10 Mn |
| Mar 31, 2026 | -1.01 Bn |
| Dec 31, 2025 | -1.02 Bn |
| Sep 30, 2025 | -1.29 Bn |
| Jun 30, 2025 | -1.32 Bn |
| Mar 31, 2025 | -1.38 Bn |
| Dec 31, 2024 | -1.39 Bn |
| Sep 30, 2024 | -1.40 Bn |
| Jun 30, 2024 | -1.42 Bn |
| Mar 31, 2024 | -1.42 Bn |
| Dec 31, 2023 | -1.41 Bn |
| Sep 30, 2023 | -1.41 Bn |
| Jun 30, 2023 | -1.40 Bn |
| Mar 31, 2023 | -1.40 Bn |
| Dec 31, 2022 | -1.38 Bn |
| Sep 30, 2022 | -1.38 Bn |
| Jun 30, 2022 | -1.36 Bn |
| Mar 31, 2022 | -1.35 Bn |
| Dec 31, 2021 | -1.32 Bn |
| Sep 30, 2021 | -1.30 Bn |